The global iron deficiency anemia (IDA) market encompasses the sector dedicated to the diagnosis, treatment, and management of iron deficiency anemia, a condition characterized by inadequate iron levels in the body. This deficiency leads to decreased hemoglobin production and impaired oxygen transport throughout the body. The market includes various therapies, such as oral and parenteral iron supplements, diagnostic tools, and healthcare services aimed at addressing this widespread health issue.